3SBio Announces Changes to its Board of Directors

3SBio Inc. (NASDAQ:SSRX), a leading biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China, announced changes to its board of directors (the "Board"). Ms. Liping Xu, Executive Director and Vice President, will retire from the Board and her position as a company officer for health reasons, effective March 10, 2010. Ms. Xu was one of the founders of the company and has been a director of 3SBio and its predecessor company, Shenyang Sunshine, since 1993. Concurrently, effective March 10, 2010, Mr. Peiguo Cong will join the Board and serve as an independent, non-executive director.

Mr. Dan Lou,...

Want to see the full article?

• Purchase this article for only $3.00